Stocks and Investing Stocks and Investing
Mon, August 15, 2022

Matthew Harrison Maintained (AVIR) at Sell with Increased Target to $7 on, Aug 15th, 2022


Published on 2024-10-27 22:39:41 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Atea Pharmaceuticals, Inc." (AVIR) at Sell with Increased Target from $6 to $7 on, Aug 15th, 2022.

Matthew, nor any peers, have made any analyst calls on AVIR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources